TABLE III.
Covariate | Total (N = 120) | Hazard Ratio (95% CI) | p value |
---|---|---|---|
Age | 1.03 (1.01–1.06) | 0.003 | |
Sex | |||
Male | 70 | 1.00 (reference) | |
Female | 50 | 0.56 (0.33–0.94) | 0.03 |
Race | |||
White | 103 | 1.00 (reference) | |
Black | 11 | 2.63 (1.14–6.11) | 0.02 |
Asian/Pacific Islander | 6 | 1.55 (0.45–5.22) | 0.48 |
T Stage | |||
T3 | 70 | 1.00 (reference) | |
T4 | 50 | 0.95 (0.57–1.82) | 0.95 |
N Stage | |||
N0 | 82 | 1.00 (reference) | |
N1 | 38 | 1.94 (1.10–3.42) | 0.02 |
M Stage | |||
M0 | 115 | 1.00 (reference) | |
M1 | 5 | 10.13 (3.33–30.86) | <0.001 |
Treatment | — | ||
Surgery | 56 | 1.00 (reference) | |
Surgery + RT | 48 | 1.57 (0.88–2.78) | 0.12 |
Surgery + Chemotherapy | 4 | 1.94 (0.54–6.94) | 0.31 |
Surgery + Immunotherapy | 5 | 2.24 (0.48–10.41) | 0.31 |
Surgery + CRT | 7 | 1.09 (0.38–3.19) | 0.87 |
Margins | |||
Negative | 98 | 1.00 (reference) | |
Positive | 22 | 1.07 (0.56–2.03) | 0.85 |
Neck Dissection (LNY ≥ 18) | |||
No | 76 | 1.00 (reference) | |
Yes | 44 | 2.23 (1.17–4.24) | 0.02 |
Neck Dissection (LNY ≥ 1)* | |||
No | 50 | 1.00 (reference) | |
Yes | 73 | 1.54 (0.81–2.93) | 0.19 |
Note: Bold indicates P‐value <0.05.
CI = confidence interval; CRT = chemoradiotherapy; LNY = lymph node yield; RT = radiation therapy.
For regression with Neck Dissection (LNY ≥ 1), N = 123;